98BAdministration of Schedule 8 MDMA or Schedule 8 psilocybine—nurse or nurse practitioner

98B Administration of Schedule 8 MDMA or Schedule 8 psilocybine—nurse or nurse practitioner

A nurse or nurse practitioner must not administer Schedule 8 MDMA or Schedule 8 psilocybine—

(i) the nurse or nurse practitioner is authorised to do so under regulation 78A(1); and

(ii) the Schedule 8 MDMA or Schedule 8 psilocybine is administered for the treatment of another person; and

(iii) the Schedule 8 MDMA or Schedule 8 psilocybine is administered not merely for the purpose of supporting the drug dependence of that person; and

(iv) the nurse or nurse practitioner has taken all reasonable steps to ascertain the identity of the person to whom the Schedule 8 MDMA or Schedule 8 psilocybine is to be administered; or

(b) unless—

(i) the administration is to a participant in a clinical trial that is approved by or notified to the Commonwealth Secretary under the Therapeutic Goods Act 1989 of the Commonwealth and approved by a human research ethics committee; and

(ii) the nurse or nurse practitioner is authorised to do so under regulation 78A(2); and

(iii) the nurse or nurse practitioner is not the participant in the clinical trial; and

(iv) the administration is for the purpose of the clinical trial; and

(v) the administration is not merely for the purpose of supporting the drug dependence of the participant; and

(vi) the nurse or nurse practitioner has taken all reasonable steps to ascertain the identity of the participant to whom the Schedule 8 MDMA or Schedule 8 psilocybine is to be administered.

Reg. 98C inserted by S.R. No. 124/2025 reg. 28.